| 1 |
Iqubal MK, Kaur H, Md S, Alhakamy NA, Iqubal A, Ali J, Baboota S. A technical note on emerging combination approach involved in the onconanotherapeutics. Drug Deliv 2022;29:3197-212. [PMID: 36226570 DOI: 10.1080/10717544.2022.2132018] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Das SS, Moitra I, Das S, Singh N, Verma PRP, Singh SK. Conventional to Nanoscale-Based Carrier Systems in the Management of Ovarian Cancer. Hormone Related Cancer Mechanistic and Nanomedicines 2022. [DOI: 10.1007/978-981-19-5558-7_5] [Reference Citation Analysis]
|
| 3 |
Chowdhury M, Kumar Das P. Paclitaxel-Loaded Biotinylated Fe2+-Doped Carbon Dot: Combination Therapy in Cancer Treatment. ACS Appl Bio Mater 2021;4:5132-44. [PMID: 35006997 DOI: 10.1021/acsabm.1c00348] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 4 |
Jiang G, Wang X, Zhou Y, Zou C, Wang L, Wang W, Zhang D, Xu H, Li J, Li F, Luo D, Ma X, Ma D, Tan S, Wei R, Xi L. TMTP1-Modified, Tumor Microenvironment Responsive Nanoparticles Co-Deliver Cisplatin and Paclitaxel Prodrugs for Effective Cervical Cancer Therapy. Int J Nanomedicine 2021;16:4087-104. [PMID: 34163161 DOI: 10.2147/IJN.S298252] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 5 |
Carrion CC, Nasrollahzadeh M, Sajjadi M, Jaleh B, Soufi GJ, Iravani S. Lignin, lipid, protein, hyaluronic acid, starch, cellulose, gum, pectin, alginate and chitosan-based nanomaterials for cancer nanotherapy: Challenges and opportunities. International Journal of Biological Macromolecules 2021;178:193-228. [DOI: 10.1016/j.ijbiomac.2021.02.123] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 13.5] [Reference Citation Analysis]
|
| 6 |
Levit SL, Tang C. Polymeric Nanoparticle Delivery of Combination Therapy with Synergistic Effects in Ovarian Cancer. Nanomaterials (Basel) 2021;11:1048. [PMID: 33923947 DOI: 10.3390/nano11041048] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 7 |
Li Y, Gao Y, Zhang X, Guo H, Gao H. Nanoparticles in precision medicine for ovarian cancer: From chemotherapy to immunotherapy. International Journal of Pharmaceutics 2020;591:119986. [DOI: 10.1016/j.ijpharm.2020.119986] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 8 |
Wi TI, Won JE, Lee CM, Lee JW, Kang TH, Shin BC, Han HD, Park YM. Efficacy of Combination Therapy with Linalool and Doxorubicin Encapsulated by Liposomes as a Two-in-One Hybrid Carrier System for Epithelial Ovarian Carcinoma. Int J Nanomedicine 2020;15:8427-36. [PMID: 33149585 DOI: 10.2147/IJN.S272319] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 9 |
Hwang D, Ramsey JD, Kabanov AV. Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. Adv Drug Deliv Rev 2020;156:80-118. [PMID: 32980449 DOI: 10.1016/j.addr.2020.09.009] [Cited by in Crossref: 100] [Cited by in F6Publishing: 111] [Article Influence: 33.3] [Reference Citation Analysis]
|
| 10 |
Hong Y, Che S, Hui B, Wang X, Zhang X, Ma H. Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prodrug and Curcumin Co-Encapsulated Nanomedicine. Drug Des Devel Ther 2020;14:2263-74. [PMID: 32606596 DOI: 10.2147/DDDT.S241291] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 11 |
Alavi S, Haeri A, Mahlooji I, Dadashzadeh S. Tuning the Physicochemical Characteristics of Particle-Based Carriers for Intraperitoneal Local Chemotherapy. Pharm Res 2020;37. [DOI: 10.1007/s11095-020-02818-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 12 |
Kamal MM, Akter S, Lin CN, Nazzal S. Sulforaphane as an anticancer molecule: mechanisms of action, synergistic effects, enhancement of drug safety, and delivery systems.Arch Pharm Res. 2020;43:371-384. [PMID: 32152852 DOI: 10.1007/s12272-020-01225-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 13 |
Yamada KJ, Heim CE, Xi X, Attri KS, Wang D, Zhang W, Singh PK, Bronich TK, Kielian T. Monocyte metabolic reprogramming promotes pro-inflammatory activity and Staphylococcus aureus biofilm clearance. PLoS Pathog 2020;16:e1008354. [PMID: 32142554 DOI: 10.1371/journal.ppat.1008354] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 14 |
Melnyk T, Đorđević S, Conejos-Sánchez I, Vicent MJ. Therapeutic potential of polypeptide-based conjugates: Rational design and analytical tools that can boost clinical translation. Adv Drug Deliv Rev 2020;160:136-69. [PMID: 33091502 DOI: 10.1016/j.addr.2020.10.007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 15 |
Miller HA, Magsam AW, Tarudji AW, Romanova S, Weber L, Gee CC, Madsen GL, Bronich TK, Kievit FM. Evaluating differential nanoparticle accumulation and retention kinetics in a mouse model of traumatic brain injury via Ktrans mapping with MRI. Sci Rep 2019;9:16099. [PMID: 31695100 DOI: 10.1038/s41598-019-52622-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 16 |
Bellio C, DiGloria C, Spriggs DR, Foster R, Growdon WB, Rueda BR. The Metabolic Inhibitor CPI-613 Negates Treatment Enrichment of Ovarian Cancer Stem Cells. Cancers (Basel) 2019;11:E1678. [PMID: 31671803 DOI: 10.3390/cancers11111678] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 17 |
Farran B, Montenegro RC, Kasa P, Pavitra E, Huh YS, Han YK, Kamal MA, Nagaraju GP, Rama Raju GS. Folate-conjugated nanovehicles: Strategies for cancer therapy. Mater Sci Eng C Mater Biol Appl 2020;107:110341. [PMID: 31761235 DOI: 10.1016/j.msec.2019.110341] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 18 |
Khalifa AM, Elsheikh MA, Khalifa AM, Elnaggar YSR. Current strategies for different paclitaxel-loaded Nano-delivery Systems towards therapeutic applications for ovarian carcinoma: A review article. J Control Release 2019;311-312:125-37. [PMID: 31476342 DOI: 10.1016/j.jconrel.2019.08.034] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 19 |
Hu H, Petrosyan A, Osna NA, Liu T, Olou AA, Alakhova DY, Singh PK, Kabanov AV, Faber EA Jr, Bronich TK. Pluronic block copolymers enhance the anti-myeloma activity of proteasome inhibitors. J Control Release 2019;306:149-64. [PMID: 31121280 DOI: 10.1016/j.jconrel.2019.05.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 20 |
Lin CX, Gu JL, Cao JM. The acute toxic effects of platinum nanoparticles on ion channels, transmembrane potentials of cardiomyocytes in vitro and heart rhythm in vivo in mice. Int J Nanomedicine 2019;14:5595-609. [PMID: 31413565 DOI: 10.2147/IJN.S209135] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 21 |
Pan J, Rostamizadeh K, Filipczak N, Torchilin VP. Polymeric Co-Delivery Systems in Cancer Treatment: An Overview on Component Drugs' Dosage Ratio Effect. Molecules 2019;24:E1035. [PMID: 30875934 DOI: 10.3390/molecules24061035] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 12.5] [Reference Citation Analysis]
|
| 22 |
Soni KS, Thomas D, Caffrey T, Mehla K, Lei F, O'Connell KA, Sagar S, Lele SM, Hollingsworth MA, Radhakrishnan P, Bronich TK. A Polymeric Nanogel-Based Treatment Regimen for Enhanced Efficacy and Sequential Administration of Synergistic Drug Combination in Pancreatic Cancer. J Pharmacol Exp Ther 2019;370:894-901. [PMID: 30683666 DOI: 10.1124/jpet.118.255372] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 23 |
Shen J, Wang Q, Fang J, Shen W, Wu D, Tang G, Yang J. Therapeutic polymeric nanomedicine: GSH-responsive release promotes drug release for cancer synergistic chemotherapy. RSC Adv 2019;9:37232-40. [DOI: 10.1039/c9ra07051f] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 24 |
Englert C, Brendel JC, Majdanski TC, Yildirim T, Schubert S, Gottschaldt M, Windhab N, Schubert US. Pharmapolymers in the 21st century: Synthetic polymers in drug delivery applications. Progress in Polymer Science 2018;87:107-64. [DOI: 10.1016/j.progpolymsci.2018.07.005] [Cited by in Crossref: 113] [Cited by in F6Publishing: 70] [Article Influence: 22.6] [Reference Citation Analysis]
|
| 25 |
Sun Y, Shi T, Zhou Y, Zhou L, Sun B. Folate-decorated and NIR-triggered nanoparticles loaded with platinum(IV)-prodrug plus 5-fluorouracil for targeted and chemo-photothermal combination therapy. Journal of Drug Delivery Science and Technology 2018;48:40-8. [DOI: 10.1016/j.jddst.2018.08.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 26 |
Zuo W, Li N, Zhao Y, Fu T, Fei W, Yu R, Yang J. Synchronized release of bufadienolides in a stable Lutrol F127 based solid dispersion prepared with spray congealing. Drug Development and Industrial Pharmacy 2018;44:1817-25. [DOI: 10.1080/03639045.2018.1503290] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 27 |
Chang CE, Hsieh CM, Chen LC, Su CY, Liu DZ, Jhan HJ, Ho HO, Sheu MT. Novel application of pluronic lecithin organogels (PLOs) for local delivery of synergistic combination of docetaxel and cisplatin to improve therapeutic efficacy against ovarian cancer. Drug Deliv 2018;25:632-43. [PMID: 29463123 DOI: 10.1080/10717544.2018.1440444] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 28 |
Chaurasiya S, Mishra V. Biodegradable nanoparticles as theranostics of ovarian cancer: an overview. Journal of Pharmacy and Pharmacology 2018;70:435-49. [DOI: 10.1111/jphp.12860] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 29 |
Mu Q, Yu J, McConnachie LA, Kraft JC, Gao Y, Gulati GK, Ho RJY. Translation of combination nanodrugs into nanomedicines: lessons learned and future outlook. J Drug Target 2018;26:435-47. [PMID: 29285948 DOI: 10.1080/1061186X.2017.1419363] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 30 |
Du S, Zhang L, Han K, Chen S, Hu Z, Chen W, Hu K, Yin L, Wu B, Guan Y. Combined Phycocyanin and Hematoporphyrin Monomethyl Ether for Breast Cancer Treatment via Photosensitizers Modified Fe 3 O 4 Nanoparticles Inhibiting the Proliferation and Migration of MCF-7 Cells. Biomacromolecules 2018;19:31-41. [DOI: 10.1021/acs.biomac.7b01197] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 31 |
Shen W, Chen X, Luan J, Wang D, Yu L, Ding J. Sustained Codelivery of Cisplatin and Paclitaxel via an Injectable Prodrug Hydrogel for Ovarian Cancer Treatment. ACS Appl Mater Interfaces 2017;9:40031-46. [PMID: 29131563 DOI: 10.1021/acsami.7b11998] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 13.7] [Reference Citation Analysis]
|
| 32 |
Soni KS, Lei F, Desale SS, Marky LA, Cohen SM, Bronich TK. Tuning polypeptide-based micellar carrier for efficient combination therapy of ErbB2-positive breast cancer. J Control Release 2017;264:276-87. [PMID: 28870832 DOI: 10.1016/j.jconrel.2017.08.038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 33 |
Hassan S, Prakash G, Ozturk A, Saghazadeh S, Sohail MF, Seo J, Dockmeci M, Zhang YS, Khademhosseini A. Evolution and Clinical Translation of Drug Delivery Nanomaterials. Nano Today 2017;15:91-106. [PMID: 29225665 DOI: 10.1016/j.nantod.2017.06.008] [Cited by in Crossref: 146] [Cited by in F6Publishing: 126] [Article Influence: 24.3] [Reference Citation Analysis]
|
| 34 |
Dumoga S, Rai Y, Bhatt AN, Tiwari AK, Singh S, Mishra AK, Kakkar D. Block Copolymer Based Nanoparticles for Theranostic Intervention of Cervical Cancer: Synthesis, Pharmacokinetics, and in Vitro/in Vivo Evaluation in HeLa Xenograft Models. ACS Appl Mater Interfaces 2017;9:22195-211. [DOI: 10.1021/acsami.7b04982] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 35 |
Dandawate P, Subramaniam D, Anant S. Targeting Cancer Stem Cells by Functional Foods and Their Constituents. Food Toxicology 2016. [DOI: 10.1201/9781315371443-23] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 36 |
Ding Y, Su S, Zhang R, Shao L, Zhang Y, Wang B, Li Y, Chen L, Yu Q, Wu Y, Nie G. Precision combination therapy for triple negative breast cancer via biomimetic polydopamine polymer core-shell nanostructures. Biomaterials 2017;113:243-52. [PMID: 27829203 DOI: 10.1016/j.biomaterials.2016.10.053] [Cited by in Crossref: 76] [Cited by in F6Publishing: 81] [Article Influence: 10.9] [Reference Citation Analysis]
|
| 37 |
Zhang P, He W, Zhang H, Huang C, Zhao D, Luan Y. Multifunctional Mixed Micelles for Efficient Docetaxol Delivery for Cancer Therapy. ChemPlusChem 2016;81:1237-44. [DOI: 10.1002/cplu.201600363] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 38 |
Meng F, Han N, Yeo Y. Organic nanoparticle systems for spatiotemporal control of multimodal chemotherapy. Expert Opin Drug Deliv 2017;14:427-46. [PMID: 27476442 DOI: 10.1080/17425247.2016.1218464] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 39 |
Pan Q, Xue M, Xiao SS, Wan YJ, Xu DB. A Combination Therapy with Baicalein and Taxol Promotes Mitochondria-Mediated Cell Apoptosis: Involving in Akt/β-Catenin Signaling Pathway. DNA Cell Biol 2016;35:646-56. [PMID: 27414207 DOI: 10.1089/dna.2016.3312] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 40 |
Vishwasrao HM, Master AM, Seo YG, Liu XM, Pothayee N, Zhou Z, Yuan D, Boska MD, Bronich TK, Davis RM, Riffle JS, Sokolsky-papkov M, Kabanov AV. Luteinizing Hormone Releasing Hormone-Targeted Cisplatin-Loaded Magnetite Nanoclusters for Simultaneous MR Imaging and Chemotherapy of Ovarian Cancer. Chem Mater 2016;28:3024-40. [DOI: 10.1021/acs.chemmater.6b00197] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 41 |
Cheng Q, Liu Y. Multifunctional platinum-based nanoparticles for biomedical applications: Platinum-based nanoparticles for biomedical applications. WIREs Nanomed Nanobiotechnol 2017;9:e1410. [DOI: 10.1002/wnan.1410] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 42 |
Soni KS, Desale SS, Bronich TK. Nanogels: An overview of properties, biomedical applications and obstacles to clinical translation. J Control Release 2016;240:109-26. [PMID: 26571000 DOI: 10.1016/j.jconrel.2015.11.009] [Cited by in Crossref: 302] [Cited by in F6Publishing: 306] [Article Influence: 37.8] [Reference Citation Analysis]
|
